Literature DB >> 6435165

Epidemic of gynecomastia among illegal Haitian entrants.

R W Sattin, A Roisin, M E Kafrissen, J B Dugan, L S Farer.   

Abstract

Gynecomastia may occur as a normal physiologic development at certain ages or as a result of a variety of pathological conditions. An outbreak of gynecomastia was investigated at two processing centers of the Immigration and Naturalization Service (INS) between December 2, 1981, and May 14, 1982. At the Fort Allen Service Processing Center, Puerto Rico, gynecomastia was initially detected in 77 of 540 Haitian male entrants (14 percent) and in only 6 of 186 male employees of the center (3 percent) who were 18-50 years old; the difference in prevalence was statistically significant. At the Krome North Service Processing Center in Miami, Fla., gynecomastia was initially detected in 52 of 512 Haitian males 18-50 years old (10 percent). Two case-control studies did not demonstrate an association between gynecomastia and a number of factors that might have been related to an exogenous estrogen or to a substance with an estrogenic effect. Estrogen or estrogen-like substances were not found in food, water, or environmental samples. When the populations were rescreened several months later, 76 of the persons with gynecomastia detected in the first screening had had total or partial remission. Persons with remission had arrived earlier--a mean of 21.6 days for those at Fort Allen and 36.7 for those at Krome--than did those with newly detected gynecomastia and those with continuing cases. The difference in arrival dates was significant (P less than .005 for Fort Allen and P less than .001 for Krome). These results, in view of nutritional deprivation in Haiti, suggest that these cases may have been an outbreak of refeeding gynecomastia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435165      PMCID: PMC1424620     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  9 in total

1.  Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases.

Authors:  M J WILLIAMS
Journal:  Am J Med       Date:  1963-01       Impact factor: 4.965

2.  Design of a biological assay method for the detection and estimation of estrogenic residues in the edible tissues of domestic animals treated with estrogens.

Authors:  E J UMBERGER; G H GASS; J M CURTIS
Journal:  Endocrinology       Date:  1958-12       Impact factor: 4.736

3.  A simple radioimmunological method for the determination of plasma total oestriol during pregnancy.

Authors:  A Craig
Journal:  Clin Chim Acta       Date:  1976-05-03       Impact factor: 3.786

Review 4.  Sex-hormone-binding globulin.

Authors:  D C Anderson
Journal:  Clin Endocrinol (Oxf)       Date:  1974-01       Impact factor: 3.478

5.  Lindane toxicity and protein-deficient diet.

Authors:  E M Boyd; C P Chen
Journal:  Arch Environ Health       Date:  1968-08

6.  The occupational hazards of formulating oral contraceptives--a survey of plant employees.

Authors:  J M Harrington; G F Stein; R O Rivera; A V de Morales
Journal:  Arch Environ Health       Date:  1978 Jan-Feb

7.  Gynecomastia as a physical finding in normal men.

Authors:  F Q Nuttall
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

8.  Weak estrogenic activity of lindane in rats.

Authors:  R B Raizada; P Misra; P Saxena; K K Datta; T S Dikshith
Journal:  J Toxicol Environ Health       Date:  1980-05

9.  Improved ultrafiltration method for determining unbound cortisol in plasma.

Authors:  I Jerkunica; J Sophianopoulos; D Sgoutas
Journal:  Clin Chem       Date:  1980-11       Impact factor: 8.327

  9 in total
  2 in total

Review 1.  Gynaecomastia--pathophysiology, diagnosis and treatment.

Authors:  Harmeet S Narula; Harold E Carlson
Journal:  Nat Rev Endocrinol       Date:  2014-08-12       Impact factor: 43.330

2.  Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line.

Authors:  V Go; J Garey; M S Wolff; B G Pogo
Journal:  Environ Health Perspect       Date:  1999-03       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.